Roche Diagnostics

Investing today in tomorrow’s healthier communities

By building strong partnerships with labs, Roche provides high performance instruments, time-saving automation, trusted expertise, and unparalleled service and support. Our dedication to research and development enables clinicians and labs to provide patients with innovative, dependable sexual health testing and care. Roche’s solutions in molecular testing and sexual health enable better patient outcomes for everyone, in every community.

Roche STI Portfolio

cobas® CT/NG

cobas® CT/NG provides a solution to meet the growing demand for CT/NG Testing, delivering exceptional assay performance, providing broader information for improved patient care decisions, and enabling simplicity and flexibility to support varying throughput and workflow requirements.

The Dual-Target approach of cobas® CT/NG of both the genomic and cryptic plasmid DNA of Chlamydia trachomatis, ensures inclusion of nvCT strains for a highly sensitive test.

cobas CT/NG has been validated for use with male and female urine, clinician instructed self-collected vaginal swab specimens (collected in a clinical setting), and clinician-collected vaginal swab, endocervical swab, oropharyngeal swab and anorectal specimens collected in cobas PCR media and cervical specimens collected in PreservCyt Solution. This test is intended as an aid in the diagnosis of chlamydial and gonococcal disease in both symptomatic and asymptomatic individuals.

Learn More →

cobas® TV/MG

cobas® TV/MG provides an efficient solution to meet the growing demand for STI testing by combining two key targets into one assay. With demonstrated assay performance across a broad set of specimen types, cobas® TV/MG provides an easy and convenient method for reliable STI testing.

Highly sensitive test using a multi-copy exclusive target for TV and dual-target design for MG
Exceptional performance demonstrated in urogenital samples
Validated for IVD use for TV testing both male and female patients

Protect the integrity of lab results with layers of protection

Dual targets for CT, NG, MG, multi-copy exclusive target for TV, an Internal Control and the AmpErase® enzyme with fully automated contamination control built into every assay, which adds up to powerful productivity with confidence in test results.

Additional testing available:
> HPV
> BV / CV †
> MG & NG Resistance †
> HIV-1
> HIV-1/2 Qual
> HBV
> HCV
> HBV RNA (RUO) ‡
> HDV †

† This product is in development. This product is not available for use in the U.S.
‡ For Research Use Only. Not for use in diagnostic procedures.

Workflow

Run up to 3 tests simultaneously for faster turnaround

Simultaneous testing of infectious disease, respiratory, sexual health, and transplant assays leads to dramatic time savings and increased efficiency.

Three assays run simultaneously

Continuous loading of samples with no batching or pre-sorting required for mixed test requests

Efficient workflow

Full automation and process control of all STI tests onto a single platform, including LDTs

Single sample

Simultaneous processing of multiple tests from the same patient sample

Universal Instruments

Maximize throughput without adding team members or resources

Empowering laboratories to balance productivity, efficiency, and potential cost effectiveness with fully automated and standardized workflows, on demand testing and the proven reliability of Roche quality results.

Learn More →